Original Research and the Latest News
Recent Posts
How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%
Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success...
Market Overview: GLP-1 Agonists and the Obesity Market
Introduction to GLP-1 AgonistsGLP-1 agonists have been pivotal in the pharmaceutical market for nearly two decades, beginning...
Not Your Grandparents’ Probability of Success Forecasts
Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and...
Clinical Trial Success Rates: What Makes Some Companies Stand Out?
Our comprehensive analysis of over 30,000 clinical trials across more than 4,000 biopharmaceutical companies reveals significant...
Healthiest States Index of The USA 2024
Health and wellness are pivotal for leading a wholesome life. Good health is a blessing. Time and health are the two most...
Using Data to Optimize Clinical Trial Recruitment
The Importance of a High-Performing Clinical Trial Partnership Pharmaceutical companies are heavily dependent on clinical trials...
FDA Accelerated Approval, Breakthrough Therapy, and Fast Track Designations Supercharge Drug Development
FDA Expedited Drug Development Programs The Food and Drug Administration (FDA) follows an established and lengthy approval...
Uncovering New Catalyst Events in the Pharmaceutical and Biotech Markets
The Challenges with Predicting Catalyst Events “Chasing headlines” for catalyst events in the biotech and pharmaceutical markets...
Finding the Needle in a Haystack with NLP
The problem with Big Data is that it is so Big! This issue is especially true in the world of healthcare and drug development. ...
The Clinical Trial Powershift
Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of...
China Reshaping the Clinical Trial Pipeline
Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out...
New Developments in Alzheimer’s Treatment
OZMOSI’s predictions for where Alzheimer's treatment is headed. The Ravaging Effects of Alzheimer’s The devastation of living...
Letting the Data Tell the Story
In our previous post we described the technique for assigning categories to data, based on input from content experts within a...
Keeping up with the Pharmaceutical Industry in Asia
Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some...
Merck Diabetes Pipeline Analysis
Merck’s two blockbuster diabetes products, Janumet® and Januvia®, are DPP-4 inhibitors that generated nearly $3.3 billion in...
The Future of Innovation in Diabetes & Heart Disease
When it comes to improving the lives of patients with chronic illnesses like type-2 diabetes and heart disease, the...
New Faces in Big Pharma & the Rise of the Billion Dollar Deal
M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014. Worldwide M&A was up...
Novo Nordisk Diabetes Pipeline Analysis
Novo Nordisk remains a top player in the Diabetes market with blockbuster insulins NovoLog® and Levemir® which brought in a...
Recent Tweets
Get Started with OZMOSI
We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.
600 Warren Ave,
Spring Lake, NJ 07762